Hypoglycemia and Risk Factors for Death in 13 Years of Pediatric
                Admissions in Mozambique by Madrid, Lola et al.
1 
 
TITLE PAGE 
TITLE: Hypoglycemia and risk factors for death in 13 years of pediatric admissions in 
Mozambique  
Lola Madrid*1,2; Sozinho Acacio1,3; Tacilta Nhampossa1,3; Miguel Lanaspa1,2; 
Antonio Sitoe1; Sónia Amós Maculuve1; Helio Mucavele1; Llorenç Quintó2; Betuel 
Sigaúque1,3; Quique Bassat1,2 
 
1. Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique 
2. ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - 
Universitat de Barcelona, Barcelona, Spain 
3.         Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique 
 
* Corresponding author and person to whom reprint requests should be 
addressed:  
Lola Madrid 
Address: Centro de Investigação em Saúde de Manhiça (CISM), Rua 12, Cambeve, Vila 
de Manhiça, CP1929, Maputo, Mozambique 
Phone: +34 658474242 
E-mail: lola.madrid@isglobal.org 
 
SHORT TITLE:  Hypoglycaemia in a rural Mozambican hospital 
KEYWORDS: Hypoglycaemia, blood glucose, hyperglycaemia, case fatality, risk 
factor 
WORD COUNT (ABSTRACT): 198 
WORD COUNT (MANUSCRIPT): 3530 
WORD COUNT (TITLE+ABSTRACT+MANUSCRIPT): 3744 
NUMBER OF FIGURES: 4 
NUMBER OF TABLES: 4 
2 
 
MANUSCRIPT 
ABSTRACT 
Hypoglycemia is a life-threatening complication of several diseases in childhood. We 
describe the prevalence and incidence of hypoglycemia among admitted Mozambican 
children, establishing its associated risk factors. We retrospectively reviewed 13 years 
of clinical data collected through a morbidity surveillance system ongoing in Manhiça 
District Hospital, in rural Mozambique. Logistic regression was used to identify risk 
factors for hypoglycemia and death. Minimum community-based incidence rates for 
hypoglycemia were calculated using data from the Demographic Surveillance System.  
Of the 49,089 children <15 years hospitalized in Manhiça District Hospital, 45,573 
(92.8%) had a glycemia assessment on admission. 1478 children (3.2%) presented 
hypoglycemia (<3mmol/L), of which about 2/3 (972) with levels <2.5mmol/L. 
Independent risk factors for hypoglycemia on admission and death among 
hypoglycemic children included prostration, unconsciousness, edema, malnutrition, 
bacteremia. Hypoglycemic children were significantly more likely to die (OR 7.11; 
p<0.001), with an associated CFR of 19.3% (245/1267). Overall Minimum community-
based incidence rate of hypoglycemia was 1.57 episodes/1000 CYAR, significantly 
decreasing throughout the study period. Newborns showed the highest incidences (9.47 
episodes/1000 CYAR, p<0.001). Hypoglycemia remains a hazardous condition for 
African children. Symptoms and signs associated to hypoglycemia should trigger the 
verification of glycemia and the implementation of life-saving corrective measures. 
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INTRODUCTION 
Critical illness seriously deranges metabolism in children and adults1, 2, 3. Alterations in 
blood glucose homeostasis are the most common metabolic abnormalities found in 
critically ill children4 and both, hyper- and hypoglycemia are associated with poor 
outcomes1, 3, 4. Hyperglycemia in critically ill patients is an adaptive response to stress 
related to hypovolemia, surgery, sepsis or trauma5, 6. The prevalence in tropical settings 
has been estimated between 2.9% and 10.9%7, 8 and its presence on admission 
associated with mortality 1, 9, 10. Insulin therapy is the treatment of choice, but is often 
unavailable in resource-constrained settings and can also cause iatrogenic 
hypoglycemia, potentially more harmful than sustained hyperglycemia.  
On the other side of the spectrum, hypoglycemia is also a common and life-threatening 
complication of several diseases such as severe malaria, bacterial sepsis, severe 
malnutrition and neonatal illness, among others11, 12, 13, 14, 15. Hypoglycemia has been 
extensively reported to have important influence on the outcome of very ill patients, 
both in children and adults1, 16, 17. In Africa, its prevalence among pediatric admissions 
has been estimated to range between 1.8% and 7.3% 7, 18. Use of toxic herbal 
preparations and delays in seeking medical assistance may all cause or further aggravate 
hypoglycemia in these settings. Severe and prolonged hypoglycemia can result in 
mental retardation, neurological deficits and recurrent seizures19, 20. Management of 
hypoglycemia according to WHO guidelines11 includes the rapid administration of 
exogenous glucose, preferably through an intravenous access. In the developing world, 
hypoglycemia remains an insufficiently recognized killer of children, as it is seldom 
diagnosed and whenever detected, often poorly managed, mainly in relation to the lack 
of simple equipment or trained staff. 
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We analyzed data collected throughout 13 consecutive years of systematic morbidity 
surveillance among children admitted to a rural Mozambican hospital to determine 
prevalence, incidence and risk factors associated with hypoglycemia on admission and 
mortality in those children.   
MATERIAL AND METHODS 
Study site and population  
The study was conducted in Manhiça, in Southern Mozambique. The Manhiça Health 
Research Center (CISM) runs a Demographic Surveillance System (DSS) in the area 
and a morbidity surveillance system (MSS) at Manhiça District Hospital (MDH), which 
admits around 3000 children annually. Malaria, pneumonia, diarrhea, malnutrition and 
neonatal pathologies are among the main causes of admission and under-five mortality 
in Manhiça21, where HIV prevalence is among the highest in the world22. A detailed 
description of MDH, CISM and the study area can be found elsewhere23. CISM 
provides personnel as well as valuable resources and laboratory diagnosis to MDH.  
Study design  
We present a retrospective analysis of data collected through the Manhiça MSS from 
children younger than 15 years who were admitted to MDH during a 13-year long 
period (2001-2013). 
Hospital surveillance system 
A standardized admission questionnaire, which includes demographic, clinical, 
laboratory and outcome data, was filled-in for all hospitalized children < 15 years of age 
by a clinician. Upon arrival a finger prick blood sample was collected to measure 
packed cell volume (PCV) and blood glucose concentration, and thick and thin blood 
films prepared to quantify Plasmodium falciparum parasitemia. Blood cultures were 
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systematically collected to all children under the age of 2 years, or in older children with 
clinical severity, as part of the routine microbiological surveillance ongoing in MDH. 
HIV status information was not routinely collected. Upon discharge or death, up to four 
final diagnoses -based on the ICD-10 classification of diseases- were recorded on the 
questionnaire after review of all available results. 
Laboratory methods 
Glycemia was determined using Accu-Chek® (Roche Inc., Manheim, Germany) at the 
bedside, with blood being usually collected by fingerprick. Glycemia results were 
provided either in mmol/L or mg/dL units. To simplify the analysis, all mg/dL values 
were converted into mmol/L by multiplying them by 0.0555. PCV was measured using 
a microcentrifuge and a Hawksley hematocrit reader card (Hawksley & Sons Ltd, 
Lancing, UK). Thick and thin blood films for malaria diagnosis and blood cultures were 
processed as previously described24, 25.  
Clinical definitions 
All case definitions were based on admission data from the standardized questionnaires. 
Children were categorized into three groups according to blood glucose levels: 1) 
Hypoglycemia: blood glucose levels <3.0 mmol/L (categorized as severe if 
<2.5mmol/L), 2) Hyperglycemia: glycemia >11mmol/L, and 3) Normoglycemia: values 
between 3 and 11mmol/L. 
A malaria case was defined as a child admitted with a clinical diagnosis of malaria with 
a P. falciparum asexual parasitemia > 0 parasites/µL. Prostration was defined as the 
inability to sit unsupported or breast/feed in children not yet capable of sitting. Impaired 
consciousness was defined as a child having a Blantyre coma score less than 5. Severe 
anemia was defined as a PCV < 15% on admission. Hypothermia was defined as 
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axillary temperature <35ºC. Increased respiratory rate followed age-specific WHO 
definitions11. Respiratory distress included the presence of deep breathing or indrawing. 
Nutritional status was based on weight-for-age Z scores (WAZ), calculated using the 
least mean square method and the WHO and CDC Growth Charts26. Malnutrition was 
defined if WAZ-score was <-1 and severe malnutrition as WAZ of <-3.   
Case management 
Children with hypoglycemia were managed according to Mozambican national 
guidelines, based on the WHO guidelines11, which recommend a rapid intravenous 
correction with 5 ml/kg of 10% glucose or dextrose solution, repeated if necessary. 10% 
dextrose in normal saline or Ringer´s lactate for maintenance infusion was used to 
prevent further episodes, and feeding encouraged as soon as possible. Facilities for 
intensive care are not available at MDH. All clinical assistance and treatment of 
admitted children is free of charge. Children requiring specialized care were transferred 
to Maputo Central Hospital. 
Data management and statistical methods 
All admission questionnaires were double entered using a program written in FoxPro 
version 5.0 (Microsoft Corp., Seattle, WA, USA). Statistical analyses were done with 
Stata 13.1 (Stata Corp., College Station, TX, USA).  
Minimum community-based incidence rates (MCBIRs) for hypoglycemia were 
calculated referring cases to population denominators establishing time at risk (child 
years at risk (CYAR)) inferred from the DSS. Children did not contribute to the 
numerator or denominator for a period of 28 days after each episode of hypoglycemia or 
when they were outside the study area. The analysis of MCBIRs only takes into account 
children with a permanent identification number issued by the demography department 
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allowing the linkage of their demographic data with the morbidity surveillance. 
Children not living within the study area were excluded for incidence calculations. 
Negative binomial regression models with random effects using Likelihood Ratio Test 
were used to assess differences in incidence rates between calendar years or age groups. 
Case fatality rates (CFRs) were calculated for different glycemia levels as the number of 
patients who died with a specific glycemia level divided by the total number of patients 
with known outcome admitted in the study period. These CFRs represent in-hospital 
mortality and do not include patients absconding or being transferred. 
Qualitative variables were compared using a χ² test or Fisher´s exact test. Means of 
normally distributed variables were compared using the Student´s test or ANOVA.  
Multivariate logistic regression was used to investigate 1) Adjusted associations for 
potential risk factors for hypoglycemia on admission; 2) Adjusted associations for 
potential risk factors for hypoglycemia-related deaths. In the second analysis, given that 
the dependent variable was the final outcome (dead/alive), only children with a known 
outcome were included in the analysis (those absconding or being transferred were 
excluded). P-values from analyses performed in large samples may be confounded 
because of their dependence on sample size and may reach the significance level even 
when the association is negligible. Thus, significant associations will be interpreted in 
accordance with the effect size (OR) and classified as small (< 2), medium (2-3) or 
large (> 3)27. 
Ethics  
This study retrospectively assessed data collected in the context of routine clinical 
practice. The morbidity surveillance in place at MDH has been approved by the 
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Mozambican Ethics Committee. The analytical plan of this specific analysis was 
assessed and approved by Manhiça’s Internal Scientific committee.   
 
RESULTS 
During 13-year study period (1st January 2001-31st December 2013), 49,089 children 
<15 years of age were admitted to MDH, including 17,115 infants and 2774 newborns. 
Median age on admission was 18 months (interquartile range (IQR) 8-35). Glycemia 
results were available for 45,573 (92.8%) children (Figure 1) and in-hospital outcome 
information was missing in 4013 (8.2%) cases. Children without glycemia data were 
excluded from the analysis. 
Prevalence of dysglycemia 
On admission 1478/45,573 (3.2%) children had hypoglycemia, 2/3 of these episodes 
(972; 2.1%) being severe. Hyperglycemia was detected in 770/45,573 (1.7%) patients. 
By age group, hypoglycemia prevalence was the highest among newborns (8.8%), but 
present in all ages. Hyperglycemia was low and present in all age groups (Figure 2).  
Clinical presentation and case fatality rate of children with hypoglycemia admitted to 
the hospital 
Table 1 compares some key characteristics in children with hypoglycemia and 
normoglycemia. A significantly higher proportion of the patients with hypoglycemia 
were newborns, but median age was not significantly different between the two 
glycemia groups. Children with hypoglycemia were significantly more prone to refer 
feeding difficulties, have hypothermia or neurological impairment than their 
normoglycemic peers. They were also significantly more malnourished, with lower 
mean weight and WAZ scores, more frequently severely anemic or bacteremic. 
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Vomiting and diarrhea were not associated with having more hypoglycemia on 
admission. The odds of dying in the hospital was higher among hypoglycemic children 
(OR 7.11, 95%CI 6.11-8.27; associated CFR 19.3% vs. 3.3%, p<0.001). Figure 3 
summarizes CFRs by categorized glycemia. CFRs increased with decreasing glycemia, 
peaking at 33.3% in patients with values <1mmol/L. Importantly, CFRs also rose 
significantly for patients with hyperglycemia (associated CFR of 12.1%, p<0.001 when 
compared to CFR of normoglycemia).   
The multivariate analysis showed nine risk factors independently associated with the 
presence of hypoglycemia on admission (Table 2). History of seizures, 
unconsciousness, refusing to feed, malnutrition, edema, jaundice, prostration, P. 
falciparum infection and having a positive blood culture were all associated with 
hypoglycemia, while a history of cough was protective against it. All identified factors 
showed small effect size (OR <2 for all risk factors and OR > 0.5 for history of cough), 
except unconsciousness, whose effect size was medium:  OR = 2.13, 95% CI (1.66, 
2.72). 
Risk factors for death in children admitted with hypoglycemia 
Two hundred and forty-five children died out of the 1267 children with hypoglycemia 
on admission and outcome results, yielding an overall CFR of 19.3%. Independent risk 
factors for death in children admitted with hypoglycemia included anorexia and 
malnutrition with a small effect size (OR < 2), prostration and edema with medium 
effect size (OR 2-3), and unconsciousness, oral candidiasis positive blood culture and 
respiratory distress with large effect size (OR > 3) (Table 3).  
Minimum community-based incidence rates 
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Overall MCBIR throughout the study period was 1.57 episodes/1000 CYAR. MCBIR 
trends for hypoglycemia in all pediatric age groups during the thirteen-year long study 
period are shown in figure 4. MCBIR peaked at 3.73/1000 CYAR in 2001 (first year of 
the study) and significantly decreased subsequently, reaching the nadir in 2013 
(0.50/1000 CYAR; p<0.001). MCBIR were significantly higher for newborns (9.47 
episodes/1000 CYAR), than for any other age group (table 4, p<0.001).  
 
DISCUSSION 
The morbidity surveillance system ongoing at MDH, in rural Mozambique, has allowed 
us to retrospectively review the prevalence of hypoglycemia in nearly 50,000 pediatric 
admissions, spanning across a 13-year long period. This is perhaps the largest series 
examined in the developing world for the occurrence of this common (3.2% of children 
in this series) albeit insufficiently highlighted life-threatening complication. A study 
performed in an urban referral center in Mozambique two decades ago28 showed a 
higher prevalence (7.1%), similarly to studies conducted in a rural Kenyan hospital7 and 
in a Nigerian pediatric Emergency ward29. Other more recent studies in a high malaria-
endemic area in Mali30, or among febrile children in Tanzania12 have shown 
hypoglycemia prevalence similar to ours. More important than its frequency, its 
associated mortality risk needs to be overemphasized. Indeed, in this series, a fifth of all 
hypoglycemia cases on admission ended up dying. While it remains to be seen how 
much did hypoglycemia contribute to each individual outcome, it is clear, and has 
robustly been shown, that hypoglycemia carries an excessive and unacceptable risk of 
death7, 12, 24, 28, 29 even if only detected as a single episode31, 32. The CFR associated with 
hypoglycemia was lower in this cohort (19.3%) than in other studies12, 29. This possibly 
reflects variations in case-management and access to healthcare, but also relates to the 
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fact that no clear consensus has yet been reached regarding the glycemia cut-off level at 
which to define hypoglycemia. Indeed, different authors have proposed different 
hypoglycemia thresholds, particularly in the presence or not of malaria in the area7, 8, 12, 
29
. To allow comparisons, simplify guidelines and homogenize management, the 
scientific community should align in defining a unique value. Irrespective of the 
threshold used, mortality dramatically increases with glycemia lower than 3mmol/L, 
with a linear and steep inverse relationship between mortality and glycemia levels 
below this value. In our series, however, borderline values still carried a worse 
prognosis, with risk of death doubling in children with admission glycemia between 3-4 
mmol/L when compared to those with higher levels.  
15.9% of all hypoglycemia episodes affected newborns, and 8.8% of all admitted 
newborns had hypoglycemia, highlighting the importance of hypoglycemia in this age 
group. However, hypoglycemia also commonly affected –and killed- children of all 
ages, which justifies universal screening for hypoglycemia among all admitted children 
in the developing world.   
 
Most studies describing the incidence of hypoglycemia and associated outcomes are 
based on the determination of glycemia at a fixed point, usually admission. Our results 
are also limited by this lack of follow-up. We probably missed children who were 
normoglycemic on admission, but developed hypoglycemia subsequently. So we may 
be underestimating the incidence of hypoglycemia and the OR of death associated with 
hypoglycemia occurring during hospitalization. Similarly, we were unable to determine 
how many recurrent hypoglycemia episodes occurred in our series. Few studies in 
developing countries have monitored glycemia throughout the whole hospitalization. 
This is now possible through the innovative use of continuous glucose monitoring 
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(CGM). CGM can be performed through a subcutaneous sensor that measures the 
interstitial glucose level -closely related to the blood glucose level- every 5 minutes, 
uninterruptedly 24 hours a day, and for as long as a week. CGM is slowly being 
introduced in pediatric intensive care units from developed countries33, 34, but has not 
reached yet the developing world, possibly due to its high cost.  
 
Our large sample size gave us sufficient power to assess the association of different 
clinical and laboratorial characteristics with the presence of hypoglycemia on admission 
or with hypoglycemia-related mortality. Although many of such factors have been 
previously described in the literature, three major groups of factors stand out as 
significantly associated in our series with the risk of having hypoglycemia: 1) Not being 
able to feed35 (as directly reported by the mother, or as a consequence of an altered 
clinical condition decreasing the capacity to feed (altered consciousness or coma25, 40-42, 
prostration, a history of seizures)); 2) Malnutrition (including edema as a common sign 
typically associated with this condition); and 3) Concomitant infections such as invasive 
bacterial disease or P. falciparum malaria. Additionally, jaundice was also identified as 
an important risk factor for hypoglycemia, a finding also previously reported in 
Tanzania12. 
Fasting is a recognized risk factor causing hypoglycemia in children35. During fasting, 
plasma glucose levels are maintained within narrow limits by a delicate balance 
between endogenous glucose production deriving from glycogenolysis and 
gluconeogenesis36. Studies performed in children with malaria have demonstrated a 
relationship between fasting, hypoglycemia, severity of disease and mortality7, 37. 
Conditions that decrease consciousness may also result in a prolonged fasting state, 
explaining the strong association found between consciousness level and the risk of 
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hypoglycemia. However, as hypoglycemia per se is a cause of decreased consciousness, 
interpreting the direction of the association is not straightforward. Hypoglycemia 
should, however, always be investigated in the presence of a child unable to feed or 
unconscious.  
 
The association between malnutrition and hypoglycemia has also been firmly 
established in the past11, 13, 38. In malnourished patients glucose homeostasis38 can be 
compromised in several ways, including a lack of exogenous nutritional intake, 
decreased absorption of disaccharides because of intestinal villous atrophy, increased 
oxidative stress, or glucose uptake compromised by intestinal bacteria. In our series, 
62% of all hypoglycemic children showed were malnourished, with 19.4% being 
severely malnourished. Kenyan7 and Tanzanian12 studies had already shown a strong 
association between severe malnutrition (WAZ <-3) and hypoglycemia, but not with 
WAZ <-1.  
 
The association of hypoglycemia with bacterial sepsis14, 18,25, 26, 42 or malaria7, 14, 26 is 
also well documented. Our series also support these associations, as risk of 
hypoglycemia was increased by 68% among bacteremic patients, and by 30% in 
malaria-infected patients. In bacterial disease, hypoglycemia has been attributed to a 
series of factors, including high circulating levels of cytokines such as tumor necrosis 
factor and interleukin-6, both powerful stimulators of insulin secretion, which can then 
cause among other things inhibition of the gluconeogenic pathways39, 40. Decreased 
levels of glycemia secondary to the consumption of glucose by the Plasmodium 
parasite, hyperinsulinism caused by quinine, impaired gluconeogenesis and lack of 
adequate supplementation/oral intake are possible explanations in malaria37, 41, 42, 43. 
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Independent risk factors associated with hypoglycemia mortality are similar to those 
found associated with the risk of hypoglycemia. Again, factors related to feeding 
difficulties, or the presence of a clinical condition hindering feeding (unconsciousness, 
prostration, respiratory distress), malnutrition and concomitant severe infections (in this 
case only bacteremia) were all significantly and independently associated with a higher 
odds of dying among patients with hypoglycemia. In these patients, the multivariate 
analysis also identified edema and oral candidiasis as important prognostic factors. The 
association between mortality and these factors has not been properly described in the 
literature, but it is likely that edema is associated with kwashiorkor (protein deficient 
malnutrition) and oral candidiasis is a proxy of HIV co-infection, highly endemic in the 
Manhiça area22 and highly prevalent among malnourished patients13.  
 
Regarding hyperglycemia, we found a prevalence of 1.7%, and a significantly higher 
associated CFR (12.1%, p<0.001) when compared to normoglycemia. Other studies in 
similar settings have shown similar7 or higher8, 44 prevalence rates. Hyperglycemia is an 
insufficiently well-known risk factor for death10 in the developing world, and efforts for 
its early detection and correction should parallel those devoted to hypoglycemia. 
Glucose variability (GV) has recently emerged as a new concept and is considered to 
have important influence on the outcome of critically ill patients45, 46 and possibly cause 
more harm than sustained hyperglycemia. More studies are required, possibly using 
CGM, to specifically address this issue. 
 
We report for the first time minimum-community based incidence rates for 
hypoglycemia in Sub-Saharan Africa. Overall MCBIR throughout the study period were 
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1.57 episodes/1000 CYAR, peaking at 3.73 episodes/1000 CYAR in 2001, underscoring 
the high burden of this particularly dangerous complication. Reasons for the decreasing 
trends observed throughout the study period still need to be clarified, although we could 
hypothesize a better and earlier access to medical care or lower incidence of malaria 
and/or malnutrition in the last years in the study area. Newborns showed the highest 
incidence rates of hypoglycemia, underscoring the need to carefully follow this 
complication in this particularly vulnerable age group. 
 
Hypoglycemia is a silent and under-recognized killer of African children, and needs to 
be properly exposed, because the correction of hypoglycemia is simple and has rapid 
effects on the health of the child. However, in resource-constrained settings where 
dextrose infusion is not readily available or is operationally challenging, other 
alternatives to intravenous administration should be investigated and promoted in order 
to correct hypoglycemia in children unable to feed. In this respect, sublingual sugar or 
pre-prepared dextrose gel appear as promising treatments for the prevention and 
correction of hypoglycemia in children with hypoglycaemia30.  
Our study had several limitations. There are concerns with the accuracy of commercial 
finger-prick blood glucose assays. Advances in glucose meter technology have resulted 
in significant improvement of accuracy and precision of meters. However, those meters 
are not available in developing countries due to the higher cost. Other limitation is the 
use of the glucose meters instead of a formal laboratory serum or plasma glucose 
concentration to measure glycemia, since there are physical differences between the 
glucose concentration in compared to capillary blood, but this technology was not 
available to verify the diagnosis of hypoglycemia in our setting. Unfortunately, study 
subject only had one determination of glycemia measured on admission, and we were 
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unable to know if any recurrent hypoglycemia episodes occurred in our study. Due to 
there is no universally applicable definition of hypoglycaemia, we used the threshold 
established by national guidelines. Different glycemia cut-off levels could modify the 
results.  
 
CONCLUSION 
Hypoglycemia is a common complication of many conditions causing hospitalization in 
Mozambican children, and is associated with unacceptable adverse outcomes. In 
settings similar to Manhiça, all admitted children should be screened for hypoglycemia, 
and aggressively managed when found to be hypoglycemic. A single determination on 
admission is not enough, and glycemia should be recurrently screened during 
hospitalization. Better, cheaper and more innovative diagnostic and therapeutic 
alternatives need to be urgently investigated to better address the consequences of 
hypoglycemia in developing countries.  
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Figure 1: Study profile 
  
 
Figure 2: Distribution of glycemic status, by age group 
  
Figure 3: Case fatality rates according to glycemia level 
  
Figure 4: Minimum community-based incidence rates of hypoglycemia according to 
year (vertical bars indicate 95% confidence intervals) 
 
Table 1: Univariate analysis of clinical variables and diagnosis according to glycemia group 
Variables Normoglycaemia 
n=43,325 
Hypoglycaemia 
n=1478 OR and 95%CI p value 
Socio-demographic characteristics         
Age in months (Median, IQR) 17 (8-34) 21 (8-37) 1.00 0.068* 
                                    Newborn n(%) 2,304 (5.3) 226 (15.3) 3.21 (2.77-3.73) <0.001 
               Male Gender n(%) 23,249 (53.7) 841 (57.0) 1.14 (1.03-1.27) 0.013 
  Symptoms before admission         
  Fever n(%)  39,655 (91.5) 1,207 (81.7) 0.41 (0.36-0.47) <0.001 
Cough n(%) 28,429 (65.6) 825 (55.8) 0.66 (0.60-0.73) <0.001 
Vomiting n(%) 10,134 (23.4) 362 (24.5) 1.06 (0.94-1.20) 0.32 
Diarrhea n(%) 9,326 (21.5) 308 (20.8) 0.96 (0.84-1.09) 0.52 
Difficulties to breastfeed/anorexia n(%) 5,291 (13.5) 406 (30.1) 2.76 (2.45-3.12) <0.001 
Seizures n(%) 3,486 (8.1) 211 (14.3) 1.90 (1.64-2.21) <0.001 
  Anthropometrics         
Weight in Kg (mean±SD) 10.3 (5.9) 9.6 (5.9) 0.98 (0.97-0.99) <0.001 
Malnutrition  (WAZ <-1DS)  n(%)  24,111 (55.7) 908 (61.4) 1.27 (1.14-1.41) <0.001 
Severe malnutrition(WAZ<-3DS) n(%) 5,884 (14.6) 252 (19.4) 1.41 (1.22-1.62) <0.001 
WAZ  score (mean±SD) -1.41 (1.5) -1.76 (1.4) 1.17 (1.13-1.22) <0.001 
  Symptoms and signs on admission         
Axillary temp. (ºC)  (mean±SD)  37.9 (1.3) 37.6 (1.5) 0.86 (0.83-0.89) <0.001 
Hypothermia (ax. temp. <35ºC) n(%) 99 (0.2) 26 (1.8) 7.82 (5.06-12.09) <0.001 
Respiratory rate (mean±SD) 45.5 (15.2) 47.0 (18.5) 1.01 (1.00-1.01) <0.001 
Increased respiratory rate n(%) 24,211 (55.9) 834 (56.5) 1.02 (0.92-1.14) 0.67 
Respiratory distress n(%) 9,373 (21.7) 427 (29.0) 1.47 (1.31-1.65) <0.001 
Dehydration n(%) 6,935 (16.0) 292 (19.8) 1.29 (1.14-1.47) <0.001 
Pallor n(%) 7,789 (18.0) 316 (21.4) 1.24 (1.09-1.41) <0.001 
Jaundice n(%) 613 (1.4) 55 (3.7) 2.69 (2.03-3.57) <0.001 
Edema n(%) 2,678 (6.2) 134 (9.1) 1.51 (1.26-1.81) <0.001 
Stiff neck n(%) 399 (0.9) 20 (1.4) 1.48 (0.94-2.33) 0.09 
Prostration n(%) 6,613 (15.3) 489 (33.1) 2.75 (2.45-3.07) <0.001 
BCS on admission (mean ±SD) 4.9 (0.5) 4.5 (1.2) 4.10 (3.72-4.52) <0.001 
Unconsciousness (BCS <5) n(%) 2,270 (5.3) 289 (19.7) 4.42 (3.85-5.06) <0.001 
Deep coma  (BCS ≤2) n(%)  693 (1.6) 146 (9.9) 6.77 (5.61-8.17) <0.001 
  Investigation          
P. falciparum Malaria n(%)  22,186 (54.4) 716 (56.2) 1.07 (0.96-1.20) 0.21 
HIV n(%) 341 (22.1) 12 (27.9) 0.73 (0.37-1.45) 0.37 
Severe anemia n(%) 1,653 (4.2) 77 (6.5) 1.59 (1.26-2.02) <0.001 
Positive blood culture n(%) 2,803 (7.9) 177 (14.8) 2.02 (1.72-2.38) <0.001 
Clinical severe pneumonia (WHO criteria) n(%) 9,934 (23.0) 370 (25.1) 1.12 (1.00-1.27) 0.053 
  Outcome          
Length of admission (mean ±SD)  4.8 (5.8) 5.0 (6.1) 1.00 (0.99-1.01) 0.21 
Died n(%)  1,307/ 40,063(3.3) 245/1267 (19.3) 7.11 (6.11-8.27) <0.001 
*Mann-whitney test for the difference of two medians. WAZ: Weight-for-Age Z score;BCS: Blantyre Coma Score; 
Table 2: Multivariate analysis of independent risk factors associated to hypoglycemia on admission 
Risk factors Hypoglycaemia 
n=1478 Adjusted OR 95% CI p-value 
      Lower Upper   
Newborn n(%) 226 (15.3) 1.05 0.56 1.95 0.879 
Male sex n(%) 841 (57.0) 1.12 0.96 1.30 0.143 
     Malnutrition (per unit WAZ decrease) n(%) 908 (61.4) 1.12 1.07 1.18 <0.001 
History of fever n(%) 1,207 (81.7) 0.72 0.50 1.02 0.062 
History of cough n(%) 825 (55.8) 0.82 0.69 0.97 0.020 
Hypothermia on admission n(%) 26 (1.8) 3.21 0.79 12.94 0.101 
  History of seizures n(%)  211 (14.3) 1.47 1.18 1.84 0.001 
Anorexia/refusing to feed n(%) 406 (30.1) 1.67 1.38 2.02 <0.001 
Unconsciousness (BCS <5) n(%) 289 (19.7) 2.13 1.66 2.72 <0.001 
Edema n(%) 134 (9.1) 1.56 1.17 2.08 0.002 
Oral candidiasis n(%) 66 (4.5) 1.14 0.74 1.74 0.550 
Jaundice n(%) 55 (3.7) 1.95 1.25 3.03 0.003 
Respiratory distress n(%) 427 (29.0) 1.22 0.97 1.54 0.092 
Pallor n(%) 316 (21.4) 1.20 0.99 1.45 0.066 
Dehydration n(%) 292 (19.8) 0.94 0.76 1.15 0.536 
Neck stiffness n(%) 20 (1.4) 1.00 0.57 1.77 0.994 
Positive blood culture n(%) 177 (14.8) 1.66 1.32 2.09 <0.001 
P. falciparum malaria  n(%) 716 (56.2) 1.29 1.09 1.52 0.003 
Prostration n(%) 489 (33.1) 1.64 1.36 1.98 <0.001 
            
*Number and proportion of children with hypoglycemia who had severe malnutrition (i.e WAZ<-3) 
 Table 3: Multivariate analysis of independent risk factors associated to mortality in children with hypoglycemia upon admission 
 
 
 
 
 
 
 
 
 
 
 
 
Risk factors for adverse outcome 
Hypoglycemia 
deaths n/N(%)  
N=245 
Adjusted OR 95% CI p-value 
      Lower Upper   
Newborn 46/245 (18.8) 0.99 0.39 2.49 0.977 
History of fever 182/245 (74.3) 0.52 0.23 1.15 0.106 
History of seizures 53/245 (21.6) 1.08 0.59 1.98 0.798 
Anorexia/refusing to feed 117/224 (52.2) 1.74 1.02 2.97 0.042 
Hypothermia on admission 11/245 (4.5) 0.58 0.04 9.03 0.695 
Unconsciousness (BCS <5) 106/245 (43.3) 3.10 1.75 5.49 <0.001 
Prostration 160/245 (65.3) 2.34 1.30 4.23 0.005 
Oral candidiasis 31/244 (12.7) 4.80 1.80 12.8 0.001 
Edema 45/245 (18.4) 2.67 1.25 5.71 0.011 
Pallor  72/245 (29.4) 1.40 0.81 2.42 0.225 
Dehydration  67/245 (27.4) 1.06 0.59 1.89 0.846 
Jaundice  17/245 (6.9) 2.43 0.84 7.06 0.102 
Positive blood culture 75/211 (35.6) 3.24 1.85 5.66 <0.001 
P. falciparum malaria  77/206 837.4) 0.62 0.37 1.04 0.069 
Malnutrition (per unit WAZ decrease)  143/245 (58.4)* 1.21 1.03 1.42 0.019 
Respiratory distress 139/245 (56.7) 2.03 1.25 3.30 0.004 
            
*Number and proportion of children who died with hypoglycaemia and severe malnutrition (i.e WAZ<-3) 
 Table 4: Minimum community based incidence rates (MCBIR) of hypoglycemia among children admitted to Manhiça district Hospital, 
according to age group 
Age groups Subjects Episodes Time At Risk (CYAR) 
Rate estimations Model estimations 
Incidence Rate 
(Episodes per 1000 CYAR) 
95%  
Conf. Interval  IRR  
95%  
Conf. Interval  p-value 
Newborns 38442 28 2957.53 9.47 (6.54, 13.71) 1  -  < 0.0001 
28days-<1year 42682 117 33651.90 3.48 (2.90, 4.17) 0.37 (0.24, 0.55) 
1-<2years 41429 170 34865.01 4.88 (4.20, 5.67) 0.51 (0.34, 0.76) 
2-<3years 39774 139 33825.08 4.11 (3.48, 4.85) 0.43 (0.29, 0.65) 
3-<4years 38418 113 33157.82 3.41 (2.83, 4.10) 0.35 (0.23, 0.53) 
4-<5years 37461 55 32422.22 1.70 (1.30, 2.21) 0.17 (0.11, 0.27) 
5-<15years 63103 82 276806.07 0.30 (0.24, 0.37) 0.03 (0.02, 0.05) 
TOTAL 90472 704 447685.62 1.57 (1.46, 1.69) -  -  -  
p-value from Negative binomial regression model with random effects using Likelihood Ratio Test 
CYAR: Children-years at risc 
IRR: Incidence Rate Ratio 
